February 16, 2022 / 09:39 IST
Reported Consolidated quarterly numbers for Parenteral Drugs (India) are:Net Sales at Rs 1.44 crore in December 2021 down 29.21% from Rs. 2.04 crore in December 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 34.52 crore in December 2021 down 11.46% from Rs. 30.97 crore in December 2020.
EBITDA stands negative at Rs. 3.22 crore in December 2021 down 12.59% from Rs. 2.86 crore in December 2020.
Parenteral Drug shares closed at 3.95 on February 07, 2022 (NSE)
| Parenteral Drugs (India) | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 1.44 | 2.35 | 2.04 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.44 | 2.35 | 2.04 | | EXPENDITURE | | Consumption of Raw Materials | 0.57 | 1.16 | 1.49 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.02 | 0.31 | -1.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.64 | 3.67 | 3.69 | | Depreciation | 4.33 | 4.33 | 4.34 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.43 | 0.49 | 0.83 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -7.56 | -7.60 | -7.21 | | Other Income | 0.01 | 0.01 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -7.55 | -7.59 | -7.20 | | Interest | 36.68 | 35.47 | 32.09 | | P/L Before Exceptional Items & Tax | -44.23 | -43.05 | -39.29 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -44.23 | -43.05 | -39.29 | | Tax | -9.70 | -9.44 | -8.31 | | P/L After Tax from Ordinary Activities | -34.52 | -33.61 | -30.97 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -34.52 | -33.61 | -30.97 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -34.52 | -33.61 | -30.97 | | Equity Share Capital | 29.82 | 29.82 | 29.82 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -11.58 | -11.28 | -10.41 | | Diluted EPS | -11.58 | -11.28 | -10.41 | | EPS After Extra Ordinary | | Basic EPS | -11.58 | -11.28 | -10.41 | | Diluted EPS | -11.58 | -11.28 | -10.41 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
